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Mycobacterium tuberculosisAbstract Synthesis of new and desired compounds has an everlasting demand. The present work
emphasizes on the one pot, three component microwave assisted synthesis of novel ethyl 2-methyl-
4-(pyridin-2-yl)-4H-benzo[4,5]thiazolo[3,2-a]pyrimidine-3-carboxylate derivatives by the reaction of
2-aminobenzothiazole derivatives with Pyridine 2-aldehyde and Ethyl acetoacetate in the presence
of PdCl2 as an expeditious catalyst under solvent-free condition. The salient features of this
approach are operational simplicity, convergence, short reaction time, high atom economy, easy
workup, mild reaction conditions and environmentally benign conditions. All the newly synthesized
diverse poly-functionalized tri-heterocyclic benzothiazole derivatives have been characterized by
elemental analysis and various spectroscopic methods such as FT-IR, 1H NMR, 13C NMR,
ESI-MS and Single crystal X-ray analysis (4a). All the final scaffolds have been screened for
antibacterial and antioxidant activities. Also their antitubercular activity against Mycobacterium
tuberculosis H37RV was screened.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Search on efficient organic synthesis approach that substantiates the
rapid generation of complex organic molecules from simple and readily
accessible starting materials is in vogue during recent epochs and the
interests have been engrossed a current position (Chow and Shea,
2005; de Graaff et al., 2012; Jiang et al., 2010; Shiri, 2012). The impor-
tant medicinal compounds, which are synthesized through steadfast
reactions are receiving more fascinating attention. Literature shows
that scientists have also eventually facilitated the rapid development
of new chemical entities which are available for biological evaluation.crowave
2 M.N. Bhoi et al.Non-traditional conditions and their approach to implement new
synthetic organic reactions have gained popularity, primarily to cir-
cumvent growing environmental concerns (Pillai et al., 2002;
Raghavendra et al., 2007). Microwave assisted reaction is an invalu-
able technology for synthesis of organic compounds with respect to
time as it decelerates reaction time with enhanced yields and selectivity.
Microwave reaction under solvent free conditions is consensus in offer-
ing reduced pollution with ease in processing and handling (Bejan
et al., 2012; de la Hoz et al., 2005; Desai et al., 2006; Hayes, 2002,
2004; Kappe, 2000, 2004, 2008; Kappe et al., 2012; Khabazzadeh
et al., 2008; Perreux and Loupy, 2002; Stadler et al., 2002, 2003).
The chemistry of fused heterocycles is known to fascinate field of
investigation in therapeutic chemistry, since they have been found to
display improved biological activity. Heterocyclic compounds show
significant role in both medicinal chemistry and their constitution in
natural products. Among them, benzothiazole derivatives have
received substantial attention in synthetic organic chemistry with
numerous significant and valuable applications in the pharmaceutical
industry. From the current literature survey, benzothiazole derivatives
have shown various biological activities (Bhoi et al., 2015a, 2015b,
2014; Boer and Gekeler, 1995; Borad et al., 2015; Bretzel et al.,
1993; Hutchinson et al., 2001; Klusa, 1995; Pande et al., 1982; Singh
et al., 1975; Singh and Vaid, 1986; Huang and Yang, 2006; Jiang
et al., 2009, 2011; Wu et al., 2014a, 2014b; Yang et al., 2013; Zuo
et al., 2012) used in material science and in other industrial applica-
tions (Choudhary et al., 2013; Hopper, 1993; Zhang et al., 2001).
The important and pharmacological properties of benzothiazole
derivatives along with their improved synthetic methods allow a facile
access to these heterocyclic compounds. Recently, many efforts have
been dedicated to improve new and highly effective synthetic protocols
such as [3 + 2] cycloadditions, transition metal catalyzed cyclization
and multicomponent coupling reactions for the synthesis of derivatives
of benzothiazole (Bastug et al., 2012; Jaseer et al., 2010; Karle et al.,
2012; Noolvi et al., 2012; Sahu et al., 2012a; Tale, 2002; Trapani
et al., 1996; Xue et al., 2013). Typically, multi-component reactions
(MCRs) are an influential tool which attract much more focus in syn-
thetic organic reactions owing to the complex molecules with varied
range of complexity where the starting materials are easily available
(Benetti et al., 1995; Do¨mling, 2006; Kappe, 2002; Langer, 2001;
Nair et al., 2003; Ramo´n and Yus, 2005; Simon et al., 2004). Thus,
MCRs are influenced by microwave and solvent free condition as a
powerful green alternative over the conventional synthesis (Devineni
et al., 2013; Eynde et al., 2001; Kappe, 2000, 2002; Kappe and
Stadler, 2004; Leadbeater et al., 2006; Oliver Kappe, 1993; Saxena
and Chandra, 2011).
The Biginelli reaction is recognized multicomponent reaction for
the synthesis of 4H-pyrimido[2,1-b]benzothiazoles and associated poly-
heterocycles (Chebanov et al., 2010; Ranu et al., 2000; Sedash et al.,
2012). Since 1893, a one pot, three-component condensation reaction
between aldehyde, b-ketoesters and urea was first time reported by
Biginelli (Biginelli and Gazz, 1893) to produce 3,4-dihydropyrimidin-
2-(1H)one. Compound 2-amino benzothioazoles and
2-aminobenzimidazoles derivatives are used in place of urea
(Alajarin et al., 1995; Shaabani et al., 2005). The Biginelli reaction
can be carried out by heating as well as by acid and base catalysts.
Recently, catalysts such as FeF3 (Atar and Jeong, 2014), Kaolin
(Sahu et al., 2013), N,N-dichlorobis(2,4,6-trichlorophenyl)urea (Rao
et al., 2011), hydrotalcite (Sahu et al., 2012b), TBAHS (Nagarapu
et al., 2013), AlCl3 (Sahu et al., 2012c), and Zn(ClO4)26H2O(Kaur
et al., 2015; Singh et al., 2013) have shown to be effective for the syn-
thesis of 4H-pyrimido[2,1-b]benzothiazoles. Although these methods
afford good results, there is yet a great demand for quick and eco-
friendly catalytic MCRs conditions. Our aim is to find out the best
environmental friendly catalytic system for a one-pot reaction through
microwave assisted synthesis under solvent free condition.
Encouraged by the auspicious biological activity of the structurally
diverse heterocycles with fused heterocyclic systems and our
continuing research plan on the synthesis of therapeutically interestingPlease cite this article in press as: Bhoi, M.N. et al., Novel benzothiazole containing
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bioactivity. An efficient, one pot three component synthesis of ethyl
2-methyl-4-(pyridin-2-yl)-4H-benzo[4,5]thiazolo[3,2-a] pyrimidine-3-
carboxylate derivatives by reaction between various derivatives of
2-amino-benzothiazole with Pyridine 2-aldehyde and Ethyl acetoac-
etate using PdCl2 as an efficient catalyst under microwave assisted
solvent-free conditions, with better yield and short reaction time is
introduced to develop new structural motifs with promising bioactiv-
ity. We have evaluated their antibacterial activity against gram +ve
and gram ve bacterial strains and antitubercular activity against
Mycobacterium tuberculosis H37RV and also screened antioxidant
activity.
2. Material and methods
2.1. Chemistry
All chemicals and solvents were acquired from commercial
sources (Aldrich-Sigma and Merck chemical suppliers). The
reactions were scrutinized by thin layer chromatography
(TLC) and judged by the consumption of starting material.
TLC was performed on silica gel G 60 F254 (Merck) plate. It
was visualized by UV radiation, exposure to iodine vapor
and spray reagent also. Column chromatography was con-
ducted over silica gel 60 (60–120 lm). CEM Discover micro-
wave system (model No.: 908010; make up CEM Matthews.
Inc, USA) was used for synthesis with external IR temperature
control. The melting points recorded on optimelt automated
melting point system were uncorrected. IR spectra were
recorded on a Perkin–Elmer 377 spectrophotometer in KBr
with absorption in cm1. 1H NMR and 13C NMR spectra were
recorded on Bruker AV 400 and 100 MHz using DMSO-d6 as
solvent and TMS as an internal standard. Mass spectra were
recorded on Advion Expression CMS, USA, using Metha-
nol:Water:Formic acid (80:20:0.1) as mobile phase. Elemental
analysis was performed on vario MICRO cube, elementar
CHNS analyser serial No.: 15084053. Single crystal X-ray
diffraction intensity data of the compound 4a were collected
on an Oxford XCALIBUR-S CCD diffractometer with Cu
Ka radiation (k= 1.54184 A˚) at 195(100) K.
2.2. Synthesis of ethyl-(substituted)-2-methyl-4-(pyridin-2-yl)-
4H-benzo[4,5]thiazolo[3,2-a] pyrimidine-3-carboxylate
(4a–4l)
2.2.1. Method A (microwave assisted method)
Mixture of pyridine 2-aldehydes 1 (4.668 mmol), b-diketone
like Ethyl acetoacetate 2 (4.668 mmol) and various derivatives
of 2-amino benzothiazole 3a–3l (4.668 mmol) in 10 ml micro-
wave open vessel glass tube was placed in the cavity of a
microwave oven (CEM Discover microwave) and irradiated
for 2–5 min at 90 C under solvent-free conditions by using
PdCl2 (10 mol%) as a catalyst with continuous monitoring
of the reaction by TLC (30% Ethyl acetate: hexane). After
completion of the reaction, the reaction mixture was cooled
to room temperature and then poured into ice-water by solu-
bilizing in ethanol solvent. The precipitated solid was filtered,
and subjected to column chromatography using 20% (v/v)
Ethyl acetate : hexane mixture as an eluent to afford ethyl-(s
ubstituted)-2-methyl-4-(pyridin-2-yl)-4H-benzo[4,5] thiazolo[3,2-
a]pyrimidine-3-carboxylate (4a–4l) as pure product with
77–88% yield.4H-pyrimido[2,1-b]benzothiazoles derivatives: One pot, solvent-free microwave
16), http://dx.doi.org/10.1016/j.arabjc.2016.01.012
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As mentioned in above method same chemical ratio was taken
in a 25 ml round bottom flask. Resulting mixture was placed in
oil bath for 20–70 min at 90 C under solvent-free conditions
using PdCl2 (10 mol%) as a catalyst. The time taken by differ-
ent derivatives of 2-amino benzothiazole in the reaction is
shown in Table 3. After confirmation of each reaction using
TLC (30% Ethyl acetate: hexane), the reaction mixture was
allowed to cool at room temperature and poured in cold water
after solubilizing in ethanol solvent with a requisite volume.
The mixture was filtered continuously giving a wash of water.
The solid crude product was simply purified by column chro-
matography over silica gel using solvent system (20% ethyl
acetate: hexane) as an eluent to obtain subsequent pure pro-
duct (4a–4l) with 69–80% yield.
2.2.3. Ethyl-2-methyl-4-(pyridin-2-yl)-4H-benzo[4,5]thiazolo
[3,2-a]pyrimidine-3-carboxylate (4a)
Yellow solid, mp 175–176 C; Anal. Calcd for C19H17N3O2S:
C, 64.94; H, 4.88; N, 11.96; O, 9.11; S, 9.12%; found C,
64.81; H, 4.75; N, 11.79; S, 8.95%; IR (KBr) (tmax, cm
1):
3072 (CAHstr), 2943 (CAHstr), 1745 (C‚Ostr), 1677 (C‚Cstr),
1688 (C‚Nstr), 1352 (CANstr), 1240 (CAOstr);
1H NMR
(400 MHz, DMSO) d 8.59 (1H, dd, J= 7.5, 1.3 Hz, C6AH),
7.74 (2H, dtd, J= 9.3, 7.5, 1.6 Hz, C8&9AH), 7.42–7.08 (2H,
m, C7&4AH), 7.04 (1H, td, J= 7.5, 1.4 Hz, C2AH), 6.73
(2H, dd, J= 11.8, 4.5 Hz, C1&3AH), 6.11 (1H, s, C5AH),
4.25 (2H, q, J= 5.9 Hz, ACH2), 2.23 (3H, s, ACH3), 1.36
(3H, t, J= 5.9 Hz, ACH3);
13C NMR (100 MHz, DMSO-d6)
d 166.42, 166.12, 160.08, 157.22, 146.82, 141.40, 139.47,
127.91, 127.44, 127.15, 124.57, 121.61, 114.02, 107.69, 61.50,
55.90, 18.12, 14.70; ESI-MS: m/z calculated 351.42, found
[M+H]+ 352.4.
2.2.4. Ethyl-8-bromo-2-methyl-4-(pyridin-2-yl)-4H-benzo[4,5]
thiazolo[3,2-a]pyrimidine-3-carboxylate (4b)
Yellow solid, mp 165 C; Anal. Calcd for C19H16BrN3O2S: C,
53.03; H, 3.75; Br, 18.57; N, 9.76; O, 7.44; S, 7.45%; found C,
53.22; H, 3.55; N, 9.58; S, 7.66%; IR (KBr) (tmax, cm
1): 3042
(CAHstr), 2933 (CAHstr), 1749 (C‚Ostr), 1656 (C‚Cstr), 1675
(C‚Nstr), 1277 (CANstr), 1170 (CAOstr);
1H NMR (400 MHz,
DMSO) d 8.67 (1H, dd, J= 7.5, 1.4 Hz, C6AH), 7.77 (1H, td,
J= 7.4, 1.4 Hz, C8AH), 7.72–7.62 (2H, m, C9&4AH), 7.33
(1H, td, J= 7.4, 1.5 Hz, C7AH), 7.19 (1H, dd, J= 7.5,
1.6 Hz, C2AH), 6.47 (1H, d, J= 7.5 Hz, C1AH), 5.74 (1H, s,
C5AH), 4.25 (2H, q, J= 5.9 Hz, ACH2), 2.21 (3H, s,
ACH3), 1.36 (3H, t, J= 5.9 Hz, ACH3);
13C NMR
(100 MHz, DMSO-d6) d 166.42, 166.12, 160.08, 157.22,
146.82, 143.49, 139.47, 128.82, 127.91, 126.10, 124.22, 123.54,
121.56, 115.45, 107.69, 61.50, 55.90, 18.12, 14.70; ESI-MS:
m/z calculated 430.32, found [M+H]+ 431.3.
2.2.5. Ethyl-2,8-dimethyl-4-(pyridin-2-yl)-4H-benzo[4,5]
thiazolo[3,2-a]pyrimidine-3-carboxylate (4c)
Yellow solid, mp 148 C; Anal. Calcd for C20H19N3O2S: C,
65.73; H, 5.24; N, 11.50; O, 8.76; S, 8.77%; found C, 65.55;
H, 5.41; N, 11.69; S, 8.56%; IR (KBr) (tmax, cm
1): 3046
(CAHstr), 2946 (CAHstr), 1741 (C‚Ostr), 1651 (C‚Cstr),
1610 (C‚Nstr), 1343 (CANstr), 1230 (CAOstr);
1H NMRPlease cite this article in press as: Bhoi, M.N. et al., Novel benzothiazole containing
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7.74 (2H, dtd, J= 9.1, 7.5, 1.5 Hz, C8&9AH), 7.44–7.28 (2H,
m, C4&7AH), 6.89 (1H, dd, J= 7.5, 1.4 Hz, C2AH), 6.56
(1H, d, J= 7.5 Hz, C1AH), 6.08 (1H, s, C5AH), 4.25 (2H,
q, J= 5.9 Hz, ACH2), 2.34 (3H, s, ACH3), 2.23 (3H, s,
C3ACH3), 1.36 (3H, t, J= 5.9 Hz, ACH3);
13C NMR
(100 MHz, DMSO-d6) d 166.42, 166.12, 160.08, 157.22,
146.82, 140.75, 139.47, 135.27, 128.24, 127.91, 124.00, 122.43,
121.56, 112.72, 107.69, 61.50, 55.90, 21.21, 18.12, 14.70; ESI-
MS: m/z calculated 365.45, found [M+H]+ 366.4.
2.2.6. Ethyl-2,6-dimethyl-4-(pyridin-2-yl)-4H-benzo[4,5]
thiazolo[3,2-a]pyrimidine-3-carboxylate (4d)
Off white solid, mp 260 C; Anal. Calcd for C20H19N3O2S: C,
65.73; H, 5.24; N, 11.50; O, 8.76; S, 8.77%; found C, 65.48; H,
5.14; N, 11.35; S, 8.55%; IR (KBr) (tmax, cm
1): 3089
(CAHstr), 2923 (CAHstr), 1744 (C‚Ostr), 1625 (C‚Cstr),
1593 (C‚Nstr), 1289 (CANstr), 1249 (CAOstr);
1H NMR
(400 MHz, DMSO) d 8.61 (1H, dd, J= 7.5, 1.4 Hz, C6AH),
7.71 (2H, dtd, J= 8.9, 7.5, 1.4 Hz, C8&9AH), 7.43–7.22 (2H,
m, C4&7AH), 6.88 (1H, dd, J= 7.5, 1.4 Hz, C2AH), 6.67
(1H, t, J= 7.5 Hz, C3AH), 5.94 (1H, s, C5AH), 4.24 (2H, q,
J= 5.9 Hz, ACH2), 2.38 (3H, s, C1-CH3), 2.11 (3H, s,
ACH3), 1.37 (3H, t, J= 5.9 Hz, ACH3);
13C NMR
(100 MHz, DMSO-d6) d 166.11, 160.08, 157.22, 146.82,
139.50, 130.19, 128.61, 127.91, 127.02, 121.56, 118.62, 118.08,
107.69, 61.5, 55.58, 18.07, 14.70; ESI-MS: m/z calculated
365.45, found [M+H]+ 366.4.
2.2.7. Ethyl-2-methyl-8-nitro-4-(pyridin-2-yl)-4H-benzo[4,5]
thiazolo[3,2-a]pyrimidine-3-carboxylate (4e)
Yellow solid, mp 174–178 C; Anal. Calcd for C19H16N4O4S:
C, 57.57; H, 4.07; N, 14.13; O, 16.14; S, 8.09%; found C,
57.37; H, 4.27; N, 14.31; S, 8.22%; IR (KBr) (tmax, cm
1):
3050 (CAHstr), 2933 (CAHstr), 1737 (C‚Ostr), 1632 (C‚Cstr),
1597 (C‚Nstr), 1313 (CANstr), 1256 (CAOstr);
1H NMR
(400 MHz, DMSO) d 8.61 (1H, dd, J= 7.5, 1.4 Hz, C6AH),
8.41 (1H, d, J= 1.4 Hz, C4AH), 7.97 (1H, dd, J= 7.5,
1.4 Hz, C2AH), 7.77 (1H, td, J= 7.5, 1.4 Hz, C8AH), 7.59
(1H, dd, J= 7.5, 1.6 Hz, C9AH), 7.33 (1H, td, J= 7.5,
1.4 Hz, C7AH), 6.85 (1H, d, J= 7.5 Hz, C1AH), 5.57 (1H, s,
C5AH), 4.23 (2H, q, J= 5.9 Hz, ACH2), 2.18 (3H, s,
ACH3), 1.37 (3H, t, J= 5.9 Hz, ACH3);
13C NMR
(100 MHz, DMSO-d6) d 166.42, 166.12, 160.08, 157.22,
147.15, 146.82, 145.82, 139.47, 133.29, 127.91, 123.63, 121.56,
115.53, 112.10, 107.69, 61.50, 55.90, 18.12, 14.70; ESI-MS:
m/z calculated 396.42, found [M+H]+ 397.4.
2.2.8. Ethyl-8-chloro-2-methyl-4-(pyridin-2-yl)-4H-benzo[4,5]
thiazolo[3,2-a]pyrimidine-3-carboxylate (4f)
Fluorescent Yellow solid, mp 177–178 C; Anal. Calcd for
C19H16ClN3O2S: C, 59.14; H, 4.18; Cl, 9.19; N, 10.89; O,
8.29; S, 8.31%; found C, 59.32; H, 4.29; N, 10.65; S, 8.13%;
IR (KBr) (tmax, cm
1): 3075 (CAHstr), 2831 (CAHstr), 1741
(C‚Ostr), 1642 (C‚Cstr), 1610 (C‚Nstr), 1329 (CANstr),
1287 (CAOstr);
1H NMR (400 MHz, DMSO) d 8.67 (1H, dd,
J= 7.5, 1.4 Hz, C6AH), 7.77 (1H, td, J= 7.4, 1.4 Hz,
C8AH), 7.68 (1H, dd, J= 7.5, 1.4 Hz, C9AH), 7.49 (1H, d,
J= 1.6 Hz, C4AH), 7.33 (1H, td, J= 7.4, 1.5 Hz, C7AH),
7.03 (1H, dd, J= 7.5, 1.4 Hz, C2AH), 6.52 (1H, d,4H-pyrimido[2,1-b]benzothiazoles derivatives: One pot, solvent-free microwave
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4 M.N. Bhoi et al.J= 7.5 Hz, C2AH), 5.75 (1H, s, C5AH), 4.25 (2H, q,
J= 5.9 Hz, ACH2), 2.21 (3H, s, ACH3), 1.36 (3H, t,
J= 5.9 Hz, ACH3);
13C NMR (100 MHz, DMSO-d6) d
166.42, 166.12, 160.08, 157.22, 146.82, 141.00, 139.47, 132.27,
129.15, 127.91, 127.13, 121.56, 120.29, 117.30, 107.69, 61.50,
55.90, 18.12, 14.70; ESI-MS: m/z calculated 385.87, found
[M+H]+ 386.8.
2.2.9. Ethyl-6-chloro-2-methyl-4-(pyridin-2-yl)-4H-benzo[4,5]
thiazolo[3,2-a]pyrimidine-3-carboxylate (4g)
Pink solid, mp 195 C; Anal. Calcd for C19H16ClN3O2S: C,
59.14; H, 4.18; Cl, 9.19; N, 10.89; O, 8.29; S, 8.31%; found
C, 59.33; H, 4.39; N, 10.65; S, 8.24%; IR (KBr) (tmax,
cm1): 3012 (CAHstr), 2846 (CAHstr), 1740 (C‚Ostr), 1643
(C‚Cstr), 1669 (C‚Nstr), 1290 (CANstr), 1283 (CAOstr);
1H
NMR (400 MHz, DMSO) d 8.70 (1H, dd, J= 7.5, 1.4 Hz,
C6AH), 7.72 (2H, dtd, J= 9.1, 7.5, 1.5 Hz, C8&9AH), 7.44–
7.25 (2H, m, C4&7AH), 7.04 (1H, dd, J= 7.5, 1.4 Hz,
C2AH), 6.67 (1H, t, J= 7.5 Hz, C3AH), 6.29 (1H, s,
C5AH), 4.23 (2H, q, J= 5.9 Hz, ACH2), 2.40 (3H, s,
ACH3), 1.36 (3H, t, J= 5.9 Hz, ACH3);
13C NMR
(100 MHz, DMSO-d6) d 166.11, 160.08, 157.22, 146.82,
139.47, 137.37, 129.08, 128.21, 127.91, 125.88, 123.72, 121.56,
121.02, 107.69, 61.50, 55.58, 18.12, 14.70; ESI-MS: m/z calcu-
lated 385.87, found [M+H]+ 386.8.
2.2.10. Ethyl-8-fluoro-2-methyl-4-(pyridin-2-yl)-4H-benzo[4,5]
thiazolo[3,2-a] pyrimidine-3-carboxylate (4h)
Greenish Yellow solid, mp 160 C; Anal. Calcd for
C19H16FN3O2S: C, 61.77; H, 4.37; F, 5.14; N, 11.37; O, 8.66;
S, 8.68%; found C, 61.51; H, 4.25; N, 11.52; S, 8.83%; IR
(KBr) (tmax, cm
1): 3077 (CAHstr), 2941 (CAHstr), 1743
(C‚Ostr), 1636 (C‚Cstr), 1641 (C‚Nstr), 1370 (CANstr),
1183 (CAOstr);
1H NMR (400 MHz, DMSO) d 8.65 (1H, dd,
J= 7.5, 1.4 Hz, C6AH), 7.74 (1H, td, J= 7.5, 1.5 Hz,
C8AH), 7.62 (1H, dd, J= 7.5, 1.4 Hz, C9AH), 7.33 (1H, td,
J= 7.5, 1.5 Hz, C7AH), 7.20 (1H, dd, J= 8.1, 1.4 Hz,
C4AH), 6.78 (1H, td, J= 7.9, 1.5 Hz, C2AH), 6.61 (1H, dd,
J= 7.5, 5.1 Hz, C1AH), 6.00 (1H, s, C5AH), 4.23 (2H, q,
J= 5.9 Hz, ACH2), 2.44 (3H, s, ACH3), 1.36 (3H, t,
J= 5.9 Hz, ACH3);
13C NMR (100 MHz, DMSO-d6) d
166.42, 166.12, 160.08, 159.48, 157.22, 146.82, 139.47, 138.13,
128.01–127.80, 121.56, 117.98, 115.88, 110.25–110.05, 107.69,
61.50, 55.90, 18.12, 14.70; ESI-MS: m/z calculated 369.09,
found [M+H]+ 370.0.
2.2.11. Ethyl-8-methoxy-2-methyl-4-(pyridin-2-yl)-4H-benzo
[4,5]thiazolo[3,2-a]pyrimidine-3-carboxylate (4i)
Yellow solid, mp 150 C; Anal. Calcd for C20H19N3O3S: C,
62.97; H, 5.02; N, 11.02; O, 12.58; S, 8.41%; found C, 62.75;
H, 5.29; N, 11.27; S, 8.25%; IR (KBr) (tmax, cm
1): 3082
(CAHstr), 2932 (CAHstr), 1739 (C‚Ostr), 1629 (C‚Cstr),
1655 (C‚Nstr), 1269 (CANstr), 1181 (CAOstr);
1H NMR
(400 MHz, DMSO) d 8.60 (1H, dd, J= 7.5, 1.4 Hz, C6AH),
7.77 (1H, td, J= 7.5, 1.5 Hz, C8AH), 7.68 (1H, dd, J= 7.5,
1.4 Hz, C9AH), 7.33 (1H, td, J= 7.5, 1.6 Hz, C7AH), 7.06
(1H, d, J= 1.4 Hz, C4AH), 6.62 (1H, dd, J= 7.5, 1.4 Hz,
C2AH), 6.52 (1H, d, J= 7.5 Hz, C1AH), 5.73 (1H, s,
C5AH), 4.23 (2H, q, J= 5.9 Hz, ACH2), 3.80 (3H, s,
AOCH3), 2.58 (3H, s, ACH3), 1.36 (3H, t, J= 5.9 Hz,Please cite this article in press as: Bhoi, M.N. et al., Novel benzothiazole containing
assisted synthesis and their biological evaluation. Arabian Journal of Chemistry (20ACH3);
13C NMR (100 MHz, DMSO-d6) d 166.42, 166.12,
160.08, 157.59, 157.22, 146.82, 139.47, 136.72, 127.91, 127.49,
121.56, 118.44, 114.13, 111.15, 107.69, 61.50, 55.97, 18.12,
14.70; ESI-MS: m/z calculated 381.11, found [M+H]+ 382.1.
2.2.12. Ethyl-8-ethoxy-2-methyl-4-(pyridin-2-yl)-4H-benzo
[4,5]thiazolo[3,2-a]pyrimidine-3-carboxylate (4j)
Greenish Yellow solid, mp 141 C; Anal. Calcd for C21H21
N3O3S: C, 63.78; H, 5.35; N, 10.63; O, 12.14; S, 8.11%; found
C, 63.57; H, 5.15; N, 10.41; S, 8.29%; IR (KBr) (tmax, cm
1):
3061 (CAHstr), 2939 (CAHstr), 1747 (C‚Ostr), 1645 (C‚Cstr),
1642 (C‚Nstr), 1288 (CANstr), 1320 (CAOstr);
1H NMR
(400 MHz, DMSO) d 8.66 (1H, dd, J= 7.5, 1.4 Hz, C6AH),
7.76 (1H, td, J= 7.5, 1.4 Hz, C8AH), 7.62 (1H, dd, J= 7.5,
1.4 Hz, C9AH), 7.33 (1H, td, J= 7.4, 1.5 Hz, C7AH), 7.06
(1H, d, J= 1.4 Hz, C4AH), 6.62 (1H, dd, J= 7.5, 1.4 Hz,
C2AH), 6.53 (1H, d, J= 7.4 Hz, C1AH), 5.63 (1H, s,
C5AH), 4.21 (2H, q, J= 5.9 Hz, ACH2), 4.03 (2H, q,
J= 5.9 Hz, AOCH2), 2.41 (3H, s, ACH3), 1.35 (6H, dt,
J= 31.7, 5.9 Hz, -2CH3);
13C NMR (100 MHz, DMSO-d6) d
166.42, 166.12, 160.08, 157.29, 146.82, 139.47, 136.46, 127.91,
127.11, 121.56, 118.40, 115.70, 112.52, 107.69, 63.99, 61.50,
55.90, 18.12, 14.70, 13.83; ESI-MS: m/z calculated 395.47,
found [M+H]+ 396.4.
2.2.13. Ethyl-2-methyl-4-(pyridin-2-yl)-8-(trifluoromethoxy)-
4H-benzo[4,5]thiazolo[3,2-a] pyrimidine-3-carboxylate (4k)
Yellow solid, mp 177–180 C; Anal. Calcd for C20H16F3N3
O3S: C, 55.17; H, 3.70; F, 13.09; N, 9.65; O, 11.02; S,
7.36%; found C, 55.35; H, 3.54; N, 9.48; S, 7.12%; IR (KBr)
(tmax, cm
1): 3052 (CAHstr), 2925 (CAHstr), 1742 (C‚Ostr),
1657 (C‚Cstr), 1654 (C‚Nstr), 1370 (CANstr), 1170 (CAOstr);
1H NMR (400 MHz, DMSO) d 8.60 (1H, dd, J= 7.5, 1.4 Hz,
C6AH), 7.75 (2H, dtd, J= 9.1, 7.5, 1.5 Hz, C8&9AH), 7.42–
7.23 (1H, m, C7AH), 7.09 (1H, d, J= 1.4 Hz, C4AH), 6.74
(1H, dd, J= 7.5, 1.6 Hz, C2AH), 6.59 (1H, d, J= 7.5 Hz,
C1AH), 5.63 (1H, s, C5AH), 4.25 (2H, q, J= 5.9 Hz,
ACH2), 2.58 (3H, s, ACH3), 1.36 (3H, t, J= 5.9 Hz,
ACH3);
13C NMR (100 MHz, DMSO-d6) d 166.42, 166.12,
160.08, 157.22, 149.85, 146.82, 139.47, 131.49, 127.91, 125.37,
122.75, 122.34, 121.56, 114.16, 107.69, 61.50, 55.90, 18.12,
14.70; ESI-MS: m/z calculated 435.42, found [M+H]+ 436.4.
2.2.14. Ethyl-8-hydroxy-2-methyl-4-(pyridin-2-yl)-4H-benzo
[4,5]thiazolo[3,2-a]pyrimidine-3-carboxylate (4l)
Yellow solid, mp 177–178 C; Anal. Calcd for C19H17N3O3S:
C, 62.11; H, 4.66; N, 11.44; O, 13.06; S, 8.73%; found C,
62.39; H, 4.48; N, 11.68; S, 8.61%; IR (KBr) (tmax, cm
1):
3089 (CAHstr), 2947 (CAHstr), 1738 (C‚Ostr), 1640 (C‚Cstr),
1676 (C‚Nstr), 1393 (CANstr), 1214 (CAOstr);
1H NMR
(400 MHz, DMSO) d 8.59 (1H, dd, J= 7.5, 1.4 Hz, C6AH),
7.77 (1H, td, J= 7.4, 1.4 Hz, C8AH), 7.69 (1H, dd, J= 7.5,
1.6 Hz, C9AH), 7.33 (1H, td, J= 7.5, 1.5 Hz, C7AH), 6.95
(1H, d, J= 1.4 Hz, C4AH), 6.59–6.49 (2H, m, C1&2AH), 5.97
(1H, s, C5AH), 4.81 (1H, s, AOH), 4.24 (2H, q, J= 5.9 Hz,
ACH2), 2.23 (3H, s, ACH3), 1.35 (3H, t, J= 5.9 Hz, ACH3);
13C NMR (100 MHz, DMSO-d6) d 166.42, 166.12, 160.08,
157.22, 154.78, 146.82, 139.47, 134.83, 127.91, 126.04, 121.56,
118.57, 113.55, 111.39, 107.69, 61.50, 55.90, 18.12, 14.70;
ESI-MS: m/z calculated 367.10, found [M+H]+ 368.1.4H-pyrimido[2,1-b]benzothiazoles derivatives: One pot, solvent-free microwave
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Antibacterial activities of 4a–4l were carried out in Nutrient-
agar plates by well diffusion assay. Cultures were activated
in Nutrient broth. Isolates were inoculated in Nutrient broth
and incubated at 37 C for 24 h for activation of cultures
and then centrifuged at 3000 rpm for 15 min and the super-
natant was collected to study antibacterial activity.
Using in vitro agar well diffusion method, antimicrobial
activity experiments were carried out. The activity of 4a–4l
against test microorganisms of activated test cultures (24 h
old culture) (2 Gram negative and 2 Gram positive; viz. Enter-
obacter aerogens MTCC No. 8558, Escherichia coli MTCC
No. 1610, Micrococcus luteus MTCC No. 11948 and Bacillus
cereus MTCC No. 8557) was inoculated in molten agar and
poured into sterile plates. The volume of test culture was
0.1 ml whose optical density is equal to 0.235 at 750 nm and
was allowed to solidify. Wells with 5 mm diameter were pre-
pared at equal distance in solidified agar plates using
cup-borer. Various derivatives 4a–4l with 1000 lg/ml concen-
tration were inoculated in the wells of nutrient agar whereas
test microorganisms were inoculated by pour plate technique.
The plates were incubated at 37 C for 24 h. The inhibition
zones were measured at the end of the incubation period and
were compared and envisaged with positive and negative con-
trols where streptomycin (1000 lg/ml) is a standard taken and
the drug was dissolved in 95% DMF.
2.4. Antioxidant assay protocol
Each sample was dissolved in 95% DMF to make a concentra-
tion of 1 mg/ml and then diluted to prepare a series of concen-
trations for antioxidant assays. Reference chemicals were used
for comparison in all assays.
2.4.1. DPPH radical scavenging activity assay
The free radical scavenging activity of the 4a–4l was measured
in vitro by 2,20-diphenyl-1-picrylhydrazyl (DPPH) assay
according to the method described by Brand-Williams et al.
(1995). The stock solution was prepared by dissolving 24 mg
DPPH with 100 ml methanol and stored at 20 C as required.
The working solution was obtained by diluting DPPH solution
with DMF to attain an absorbance of about 0.98 ± 0.02 at
517 nm using the spectrophotometer. A 3 ml aliquot of this
solution was mixed with 100 ll of the sample at various con-
centrations (0–600 lg/ml) as shown in Table 5. The reaction
mixture was shaken well and incubated in the dark for
15 min at room temperature. Then the absorbance was mea-
sured at 517 nm.
The control was prepared as aforesaid without any sample.
The scavenging activity was estimated based on the percentage
of DPPH radical scavenged as per the following equation:
Scavenging effect ð%Þ
¼ Control absorbance Sample absorbance
Control absorbance
 1002.4.2. Superoxide radical scavenging activity
The superoxide radical scavenging activity was assayed
according to the reported method as shown by NishikimiPlease cite this article in press as: Bhoi, M.N. et al., Novel benzothiazole containing
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Pithawala and Jain (2014). Superoxide anions were generated
in a phenazine methosulfate–nicotinamide adenine dinu-
cleotide (PMS–NADH) system through the reaction of
PMS–NADH and oxygen. It was assayed by the reduction
of nitroblue tetrazolium (NBT). All the solutions used in this
experiment were prepared in phosphate buffer (pH 7.4). 1 ml
of NBT (156 lM), 1 ml of NADH (468 lM) and 1 ml of com-
pound (0–600 lg/ml) were mixed. The reaction was initiated by
adding 1 ml of PMS (60 lM) and the mixture was incubated at
25 C for 5 min followed by measurement of absorbance at
560 nm spectrophotometrically. The decreased absorbance of
the reaction mixture indicated increased superoxide anion
scavenging activity. The percentage inhibition was calculated
from the formula,
Inhibition ð%Þ ¼ Control absorbance Sample absorbance
Control absorbance
 100
A percent inhibition versus concentration curve was plotted
and the concentration of 4a–4l required for 50% inhibition
was determined and expressed as IC50 value. The lower IC50
value indicates high antioxidant capacity (Raghavendra
et al., 2013).
2.4.3. ABTS+ radical scavenging activity
The 2,20-azinobis (3-ethylbenzthiazoline-6-sulfonic acid), com-
monly called ABTS+ cation scavenging activity was per-
formed (Re et al., 1999). Briefly, ABTS solution (7 mM) was
reacted with potassium persulfate (2.45 mM) solution and kept
for overnight in the dark to yield a dark colored solution con-
taining ABTS+ radical cations. Prior to use in the assay, the
ABTS+ radical cation was diluted with 50% DMF for an ini-
tial absorbance of about 0.70 ± 0.02 at 745 nm, with temper-
ature control set at 30 C. Free radical scavenging activity was
assessed by mixing 300 ll of test sample with 3.0 ml of ABTS
working standard in a micro cuvette. Each concentration of
sample was taken in range of 0–600 lg/ml as shown in Table 5.
The decrease in absorbance was measured exactly one minute
after mixing the solution, and then up to 6 min. The percentage
inhibition was calculated according to the formula:
Scavenging effect ð%Þ
¼ Control absorbance Sample absorbance
Control absorbance
 100
The antioxidant capacity of test samples was expressed as EC50
(anti-radical activity), the concentration necessary for 50%
reduction of ABTS+ (Gu¨lc¸in et al., 2011).
2.5. In vitro anti-mycobacterial activity
Here we have performed in vitro anti-mycobacterial activity of
all synthesized compounds. Antimicrobial assays performed in
Lowenstein Jensen (L-J) medium. Determination of Colony
forming units (c.f.u) on Lowenstein-Jensen (L-J) – The ten-
fold dilution of standard 1 mg/mlM. tuberculosis suspension
(Canetti et al., 1969) was streaked on L-J medium for deter-
mining c.f.u in the presence and absence of plant extracts.
An M. tuberculosis suspension of 1 mg/ml is equivalent to
MacFarland standard (Kent and Kubica, 1985). One loopful
(6 ll) of this suspension was streaked on the L-J slants using4H-pyrimido[2,1-b]benzothiazoles derivatives: One pot, solvent-free microwave
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6 M.N. Bhoi et al.3 mm external diameter loop. Reagents of L-J media included
potassium di hydrogen phosphate anhydrous (Qualigens),
magnesium sulfate anhydrous (Qualigens), magnesium citrate
(Loba Chemie), L-asparagine (Hi-media, Mumbai), glycerol
(Fisher Scientific, Mumbai), and malachite green (Hi-Media,
Mumbai). The drug was incorporated in the medium at con-
centration of 2 percent v/v and 4 percent v/v of drug was dis-
solved into 100 ml of culture medium prior to inspissation. The
medium set inoculated with the standard bacterial suspension
and incubated at 37 C for 42 days. Reading was taken weekly.
For comparison, drug free control slants were used. Suscepti-
bility testing of MDR isolates was also performed against stan-
dard drugs such as rifampicin and isoniazid in the same batch
of media for comparison of cfu on drug free controls. Each test
was done in duplicate. Percentage inhibition was calculated by
mean reduction in number of colonies on drug containing as
compared to drug free controls.Table 1 Optimization of reaction by catalysts and solvents for
the synthesis of 4a by conventional method.
No. Time (h) Catalyst Solvent Temp. (C) Yielda (%)
1 0.75 PdCl2 Neat 90 75.6
2 0.95 Zn(NO3)2 Neat 90 30.7
3 1.17 Na2WO4 Neat 90 63.0
4 1.25 InCl3 Neat 90 73.2
5 1.30 Cr(NO3)2 Neat 90 51.3
6 1.33 Pb(NO3)2 Neat 90 59.7
7 1.40 Mg
(NO3)2
Neat 90 44.6
8 1.42 Cu(NO3)2 Neat 90 43.5
9 1.42 CoCl2 Neat 90 67.2
10 1.58 PdCl2 DMF 90 64.8
11 1.58 BaCl2 Neat 90 67.8
12 1.60 AlCl3 Neat 90 59.3
13 1.60 LaCl3 Neat 90 72.0
14 1.65 CaCl2 Neat 90 45.6
15 1.67 ZnCl2 Neat 90 56.6
16 1.72 Co(NO3)2 Neat 90 50.6
17 1.75 MgCl2 Neat 90 43.1
18 1.77 NiCl2 Neat 90 62.8
19 1.80 Cd(NO3)2 Neat 90 58.6
20 1.82 TiCl3 Neat 90 64.6
21 1.83 Ca(NO3)2 Neat 90 47.7
22 1.83 Sr(NO3)2 Neat 90 54.7
23 1.83 CAN Neat 90 71.8
24 1.87 CrCl3 Neat 90 65.4
25 1.92 Ba(NO3)2 Neat 90 62.7
26 2.00 NH4VO3 Neat 90 61.1
27 2.00 Bi(NO3)2 Neat 90 71.6
28 2.33 MnCl2 Neat 90 52.3
29 2.50 FeCl3 Neat 90 51.2
30 2.50 ZnOCl2 Neat 90 63.1
31 2.67 SnCl2 Neat 90 65.7
32 48.0 – DMF 90 36.7
33 72.0 – ACN 90 39.3
34 96.0 – Methanol 65 46.2
35 120 – THF 70 40.2
36 240 – DCM 45 20.5
Reaction conditions: Pyridine 2-aldehyde (1 mmol) 1, ethyl ace-
toacetate (1 mmol) 2, 2-aminobenzothiazole (1 mmol) 4a, various
catalysts (10 mol%), solvent/solvent-free conditions, D.
a Isolated yield.
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Cc
 100
where
c= control,
t= test.2.6. Statistical analysis
The determination assay for each antioxidant parameter was
carried out in thrice to minimize the percentage of error.
Statistical analysis was performed using the Statistical Package
for Social Science (IBM SPSS Statistics 20 for Windows, SPSS
Inc., Chicago, IL, USA).
3. Result and discussion
In the present study it has been interpreted and observed that
the catalysts have a major role in the organic synthesis, by
either enhancing the rate of reaction or any other aspects in
pertaining to the reaction. The same has been implemented
but however it may not divulge any enhancement in theFigure 1 Optimization study of PdCl2 as catalyst in the synthesis
of 4a.
Table 2 Optimization study of PdCl2 for the synthesis of 4a
by conventional method.
No. Catalyst (%) Time (h) Yielda (%)
1 No catalyst 10.0 45.5
2 1 2.87 58.2
3 2 2.58 62.1
4 5 2.17 68.3
5 10 0.75 75.6
6 15 0.75 76.2
7 20 0.75 74.1
Reaction conditions: Pyridine 2-aldehyde (1 mmol) 1, ethyl ace-
toacetate (1 mmol) 2, 2-aminobenzothiazole (1 mmol) 4a, various
catalysts (mol%), solvent-free conditions, 90 C, D.
a Isolated yield.
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Table 3 Comparison of yield and reaction time for the synthesis of 4a–4l.
Entry Benzothiazole Product D MW
Time (min) Yielda (%) Time (min) Yielda (%)
1 45 75.6 3 85.1
2 51 74.7 3 82.3
3 47 78.2 3 87.4
4 55 71.6 5 80.6
5 69 70.6 5 80.1
6 53 72.3 3 82.6
7 44 70.3 3 81.4
8 40 75.6 3 85.3
9 57 73.3 3 82.5
10 20 79.4 3 87.2
(continued on next page)
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Scheme 1 Synthetic route for the synthesis of title compounds under solvent-free condition.
Table 3 (continued)
Entry Benzothiazole Product D MW
Time (min) Yielda (%) Time (min) Yielda (%)
11 52 71.2 4 80.8
12 58 69.3 4 77.8
Reaction conditions: Pyridine 2-aldehyde (1 mmol) 1, ethyl acetoacetate (1 mmol) 2, various derivatives of 2-amino benzothiazole (1 mmol) 3a–
3l, PdCl2 catalyst (10 mol%), solvent-free conditions, 90 C, D & 90 C, MW.
a Isolated yield.
8 M.N. Bhoi et al.reaction which could give necessary prediction or their reac-
tions as well.
Based on promising result as shown in Table 1, we have
subsequently studied the effect of five solvents DMF
(N,N-Dimethylformamide), ACN (Acetonitrile), Methanol,
THF (Tetrahydrofuran), DCM (Dichloromethane) and vari-
ous catalysts (30) in the reaction for the synthesis of 4a from
2-amino benzothiazole 3a as a basic structural configurator
along with pyridine 2-aldehyde 1 and ethyl acetoacetate 2 by
conventional method. Methanol was used as a solvent for this
reaction at 65 C temperature and it gave 46.2% yield in 96 h
(entry 34), while the relative yield of 4a is 36.7% in 48 h by
using DMF as solvent at 90 C temperature (entry 32). But,
to our surprise, we observed that the reaction did not proceed
efficiently (Table 1, entries 33, 35–36) in other remaining sol-
vents. The yield and time of product 4a could be improved to
64.8% (1.58 h) when the reaction was performed in DMF at
90 C temperature by using PdCl2 as catalyst (entry 10).
But, the reaction proceeds efficiently when it was carried out
under neat condition by conventionally heating for 0.75 h in
the presence of PdCl2 catalyst to afford compound 4a in
75.6% yield (entry 1). InCl3 is known to have a second cata-
lyst (with 73.2% yield at 1.3 h) of interest from rest of the cat-
alysts used (entry 4). Thus, we conclude that PdCl2 catalyst
and solvent-free condition is the optimized condition for this
transformation.
The selected catalyst (PdCl2), was then optimized to work
out the maximum yield with minimized reaction time by con-
ventional method. Catalyst loading of 0, 1, 2, 5, 10, 15, andPlease cite this article in press as: Bhoi, M.N. et al., Novel benzothiazole containing
assisted synthesis and their biological evaluation. Arabian Journal of Chemistry (2020 (PdCl2 mol%) was used. Out of all these varying concentra-
tions, the maximum efficient value was obtained with 10 mol
%, as shown in Fig. 1 with maximum yield of 75.6% in
0.75 h of reaction time. The value of yield increases in a grad-
ual fashion, but is known to decrease its value in higher con-
centrations of catalysts beyond 15 mol%. This might be due
to the interference of catalyst. However, it was also noticed
to have a fixed reaction time (0.75 h) for the completion of
the 4a product as revealed in Table 2.
By following the same criteria of conventional method, we
have carried out the reaction under the CEM discover micro-
wave reactor using an open vessel technique (Dallinger and
Kappe, 2007; Stadler and Kappe, 2000; Stadler et al., 2002)
for the synthesis of 4a as well as other derivatives (see
Scheme 1). In Table 3, we have shown the comparison of reac-
tion time and yield of product by both conventional and MW
methods, comparative aspects with reference to yield and rate
of reaction. MW method was found to be better than the con-
ventional one as there is a remarkable reduction in reaction
rate. MW is superior in terms of reaction rate, where there is
a decrease from 12 to 15 folds and an increase in yield of pro-
duct from 8% to 10%.
The compound 4a was formed with 85.1% yield in 3 min of
reaction time, which was confirmed by different spectroscopic
techniques such as IR, 1H NMR, 13C NMR, Mass and elemen-
tal analysis and X-ray analysis. The IR spectrum of 4a exhib-
ited seven main peaks located at 3072, 2943, 1745, 1677, 1688,
1352, 1240 cm1, which were assigned to the (CAHstr) aro-
matic, (CAHstr) alkanes, (C‚Ostr) ester, (C‚Cstr) alkene,4H-pyrimido[2,1-b]benzothiazoles derivatives: One pot, solvent-free microwave
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Novel benzothiazole containing 4H-pyrimido[2,1-b]benzothiazoles derivatives 9(C‚Nstr) imine, (CANstr) aromatic amine, and (CAOstr) ester
respectively. The mass spectrum of 4a showed a molecular ion
peak at ESI-MS: m/z calculated 351.42, found [M+H]+ 352.4
which indicates the existence of 4a. The 1H NMR spectrum of
4a revealed pyridine ring hydrogen (PyAH) peaks shown at
8.59 (1H, dd, J= 7.5, 1.3 Hz, C6AH), 7.74 (2H, dtd,
J= 9.3, 7.5, 1.6 Hz, C8&9AH), 7.42–7.08 (1H, C7AH) d value.
Chiral center hydrogen resonated at 6.11 d and side chain
of ester group contains ACH2, ACH3 shows peak at 4.25,Figure 2 ORTEP diagram of compound 4a with the atom
numbering.
Scheme 2 Plausible mechanism for the synthe
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(J= 7.5, 1.4 Hz), 6.73 (J= 11.8, 4.5 Hz) d value.
The structure of compound 4a was also confirmed from
single-crystal X-ray diffraction studies. Fine crystals of com-
pound 4a were obtained by slow evaporation of ethyl acetate:
hexane (4:1, v/v) mixture with compound 4a. It revealed the
formation of pure 4a, which crystallizes as a monoclinic crystal
system with a space group P21/n. The results showed the
proper structure and configuration as 4a, shown in ORTEP
plot (CCDC No.: 1048059) along with the atom numbering
in Fig. 2.
Taking into consideration the entire outcome, a plausible
mechanistic pathway for the synthesis of 4a is depicted in
Scheme 2.
3.1. Antibacterial activity
Antibacterial activity of 4a–4l was carried out on Nutrient-
agar plates by well-diffusion assay against test culture.
Cultures were activated in Nutrient broth. The zone of inhibi-
tion was measured in terms of zone diameter and with the help
of that zone index was calculated where streptomycin was used
as standard.
3.1.1. Determination of activity index
The activity index of the probiotic culture was calculated as
follows:
Activity index ðA:I:Þ
¼ Mean of zone of inhibition of derivative
Zone of inhibition obtained for standard antibiotic drugsis of 4H-pyrimido[2,1-b]benzothiazoles 4a.
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Table 4 Antibacterial activity of 4a–4l.
Derivatives Enterobacter aerogens MTCC
No. 8558
Escherichia coli MTCC
No. 1610
Micrococcus luteus MTCC
No. 11948
Bacillus cereus MTCC
No. 8558
Mean value for
zone of inhibition
(mm)
Activity
index
(A.I.)
Mean value for
zone of inhibition
(mm)
Activity
index
(A.I.)
Mean value for
zone of inhibition
(mm)
Activity
index
(A.I.)
Mean value for
zone of inhibition
(mm)
Activity
index
(A.I.)
4a 22 ± 1.135 0.9166 21 ± 1.047 0.8750 19 ± 1.062 0.7916 18 ± 0.802 0.7500
4b 23 ± 1.112 0.9583 24 ± 1.124 1.0000 18 ± 1.045 0.7500 17 ± 0.812 0.7083
4c 34 ± 1.156 1.4166 31 ± 1.075 1.2910 27 ± 1.023 1.1250 19 ± 0.815 0.7916
4d 32 ± 1.142 1.3333 27 ± 1.072 1.1250 26 ± 1.047 1.0833 22 ± 0.842 0.9166
4e 30 ± 1.179 1.2500 30 ± 1.034 1.2500 28 ± 1.051 1.1666 24 ± 0.812 1.0000
4f 26 ± 1.120 1.0833 28 ± 1.159 1.1666 24 ± 1.078 1.0000 16 ± 0.823 0.6666
4g 27 ± 1.200 1.1250 25 ± 1.124 1.0416 29 ± 1.051 1.2083 19 ± 0.864 0.7916
4h 23 ± 1.141 0.9583 22 ± 1.118 0.9166 28 ± 1.023 1.1666 25 ± 0.846 1.0416
4i 24 ± 1.423 1.0000 21 ± 1.113 0.8750 21 ± 1.036 0.8750 22 ± 0.815 0.9166
4j 22 ± 1.231 0.9166 20 ± 1.076 0.8333 23 ± 1.061 0.9583 18 ± 0.841 0.7500
4k 26 ± 1.187 1.0833 25 ± 1.041 1.0416 27 ± 1.036 1.1250 21 ± 0.826 0.8750
4l 26 ± 1.154 1.0833 27 ± 1.023 1.1250 23 ± 1.078 0.9583 20 ± 0.831 0.8333
Std drug 24 – 24 – 24 – 24 –
Figure 3 Antibacterial activity of 4a–4l.
Figure 4 % DPPH radical scavenging activity assay at various
concentrations.
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Table 4 shows that all synthesized derivatives 4a–4l have
been screened with antimicrobial activity. Gram negative was
more inhibited as compared to Gram Positive bacteria. Also
4c–4g were proved to have more antibacterial property as com-
pared to the streptomycin while contrastingly 4a, 4b, 4j were
having a lesser activity index, as shown in Fig. 3; however, it
could be considered to have antimicrobial activity.
3.2. Antioxidant activity
Free radical scavenging activity was evaluated by performing
in vitro DPPH assay. As shown in Fig. 4 and Table 5, %
DPPH activity was calculated and it is found that all deriva-
tives 4a–4l have an antioxidant property.
Also the activity is dose dependent in order to scavenge the
radical. The higher concentration indicates a greater amount
of scavenging of the DPPH radical. The colored DPPH solu-
tion faded reducibly to half at an optimal concentration range
from 200 lg/ml to 400 lg/ml. This may be induced and influ-
enced due to electron transfer or the reduction of the DPPH
molecules or thought to be due to their hydrogen donating
ability (Baumann et al., 1979).
As an indirect indication it may also be a time dependent
scavenging activity. As obtained almost all of the derivatives
followed a general rule of dose dependent scavenging activity
despite the degree of electron transfer. However 4l is known
to have a more efficient scavenging property and the least
known 4a with a gradual antioxidant property. At higher con-
centration 4h has a consistent reduction of DPPH scavenging
activity to 50% with an optimal concentration range and rela-
tively lesser % scavenging activity rate, as compared to its
lower concentration. 4e and 4f showed a constant % scaveng-
ing activity following an accuracy as a dose dependent antiox-
idant reaction.
The scavenging of the ABTS+ radical by the derivatives
4a–4l was found to be higher than that of DPPH radical at
higher concentration level, indicating that they may be useful
as therapeutic agents for treating radical-related pathological4H-pyrimido[2,1-b]benzothiazoles derivatives: One pot, solvent-free microwave
16), http://dx.doi.org/10.1016/j.arabjc.2016.01.012
Table 5 % DPPH radical scavenging activity assay.
Antioxidant assays*
% DPPH radical scavenging activity assay at various concentrations
Mean ± S.E.
Derivatives 0.00 lg/ml 200 lg/ml 400 lg/ml 600 lg/ml
4a 0.00 30.00 ± 1.434 43.11 ± 2.627 76.63 ± 1.083
4b 0.00 36.71 ± 1.421 57.68 ± 2.645 76.77 ± 1.082
4c 0.00 29.48 ± 1.415 53.69 ± 2.678 79.83 ± 1.074
4d 0.00 32.75 ± 1.399 59.03 ± 2.632 84.75 ± 1.062
4e 0.00 36.18 ± 1.423 63.95 ± 2.641 86.51 ± 1.087
4f 0.00 37.75 ± 1.420 63.73 ± 2.678 84.66 ± 1.079
4g 0.00 38.47 ± 1.478 70.01 ± 2.694 79.92 ± 1.069
4h 0.00 47.02 ± 1.456 58.86 ± 2.632 75.55 ± 1.082
4i 0.00 32.06 ± 1.406 57.84 ± 2.591 83.84 ± 1.076
4j 0.00 36.71 ± 1.478 56.55 ± 2.589 82.21 ± 1.080
4k 0.00 39.99 ± 1.495 53.70 ± 2.645 79.03 ± 1.082
4l 0.00 40.73 ± 1.435 79.83 ± 2.632 84.88 ± 1.023
* p value < 0.05, data significant.
Figure 5 % Superoxide anion scavenging activity assay at
various concentrations.
Table 6 % Superoxide anion scavenging activity assay.
Antioxidant assays*
% Superoxide anion scavenging activity assay at various concentrations
Mean ± S.E.
Derivatives 0.00 lg/ml 200 lg/ml 400 lg/ml 600 lg/ml
4a 0.00 37.94 ± 0.799 55.90 ± 1.681 83.15 ± 1.294
4b 0.00 31.93 ± 0.785 52.49 ± 1.675 81.16 ± 1.285
4c 0.00 32.66 ± 0.789 53.33 ± 1.684 78.31 ± 1.279
4d 0.00 35.61 ± 0.794 59.60 ± 1.672 88.88 ± 1.286
4e 0.00 36.95 ± 0.779 55.10 ± 1.689 83.47 ± 1.284
4f 0.00 38.83 ± 0.784 61.11 ± 1.628 79.06 ± 1.296
4g 0.00 31.00 ± 0.796 50.88 ± 1.678 84.45 ± 1.276
4h 0.00 37.66 ± 0.769 69.04 ± 1.684 88.29 ± 1.263
4i 0.00 36.74 ± 0.782 62.20 ± 1.689 79.04 ± 1.284
4j 0.00 39.00 ± 0.788 65.90 ± 1.691 74.37 ± 1.275
4k 0.00 36.66 ± 0.784 58.36 ± 1.693 81.11 ± 1.263
4l 0.00 33.30 ± 0.783 65.65 ± 1.682 88.03 ± 1.290
* p value < 0.05, data significant.
Figure 6 % ABTS+ radical scavenging activity assay at various
concentrations.
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Table 7 % ABTS+ radical scavenging activity assay.
Antioxidant assays*
% ABTS+ radical scavenging activity assay at various concentrations
Mean ± S.E.
Derivatives 0.00 lg/ml 200 lg/ml 400 lg/ml 600 lg/ml
4a 0.00 12.33 ± 1.709 39.45 ± 1.227 64.93 ± 1.741
4b 0.00 22.83 ± 1.712 43.43 ± 1.233 66.83 ± 1.751
4c 0.00 25.76 ± 1.756 41.07 ± 1.2s45 68.33 ± 1.762
4d 0.00 13.94 ± 1.741 36.72 ± 1.245 70.84 ± 1.743
4e 0.00 18.42 ± 0.762 38.11 ± 1.224 63.63 ± 1.742
4f 0.00 11.63 ± 1.723 42.66 ± 1.278 68.92 ± 1.795
4g 0.00 19.20 ± 1.722 36.99 ± 1.235 73.94 ± 1.756
4h 0.00 26.39 ± 1.730 40.40 ± 1.212 76.76 ± 1.745
4i 0.00 28.23 ± 1.749 45.82 ± 1.254 84.69 ± 1.762
4j 0.00 27.46 ± 1.764 47.97 ± 1.252 65.92 ± 1.732
4k 0.00 17.30 ± 1.785 38.41 ± 1.274 75.41 ± 1.742
4l 0.00 22.73 ± 1.734 49.50 ± 1.262 68.43 ± 1.746
* p value < 0.05, data significant.
12 M.N. Bhoi et al.damage. DPPH and ABTS+ radical scavenging activities are
based on the ability of antioxidants to donate a hydrogen atom
or an electron to stabilize radicals by converting them to the
non-radical species (Binsan et al., 2008; Chandrasekara and
Shahidi, 2010). DPPH is a radical having an odd electron
and reacts with hydrogen donated from antioxidant.
In case of ABTS+ radical scavenging activity, the effective-
ness depends on the molecular weight, the number of aromatic
rings and the nature of hydroxyl group’s substitution than
the specific functional groups (Hagerman et al., 1998). Super-
oxide anion scavenging assay at various concentrations in the
range of 0–600 lg/ml was evaluated to calculate the IC50
values of each of derivatives 4a–4l. The IC50 values were cor-
respondingly in between the range of 280–400 lg/ml. The val-
ues correspond to 4a (332 lg/ml), 4b (372 lg/ml), 4c (368 lg/
ml), 4d (316 lg/ml), 4e (344 lg/ml), 4f (300 lg/ml), 4g
(390 lg/ml), 4h (281 lg/ml), 4i (301 lg/ml), 4j (285 lg/ml), 4k
(321 lg/ml), and 4l (301 lg/ml) respectively as shown in
Fig. 5 and Table 6. ABTS+ radical scavenging activity at var-
ious concentrations indicated the EC50 values as 4a (482 lg/Table 8 In vitro anti-mycobacterial activity of newly synthe-
sized compound.
Sample code Mean c.f.u. on media Percentage
inhibition (%)
Control Treatment
(100 lg/ml)
4a 155 50 67.74
4b 155 65 58.00
4c 155 42 72.90
4d 155 75 51.61
4e 155 46 70.32
4f 155 81 47.71
4g 155 49 68.38
4h 155 66 57.41
4i 155 71 54.19
4j 155 62 60.00
4k 155 55 64.51
4l 155 53 65.80
Please cite this article in press as: Bhoi, M.N. et al., Novel benzothiazole containing
assisted synthesis and their biological evaluation. Arabian Journal of Chemistry (20ml), 4b (455 lg/ml), 4c (468 lg/ml), 4d (479 lg/ml), 4e
(492 lg/ml), 4f (455 lg/ml), 4g (470 lg/ml), 4h (450 lg/ml), 4i
(425 lg/ml), 4j (425 lg/ml), 4k (462 lg/ml), and 4l (405 lg/
ml) respectively as shown in Fig. 6 and Table 7. This may shed
a new horizon in pharmaceutical based drug development and
an active drug moiety indicating the increased application of
the synthesized compounds.
3.3. In vitro anti-mycobacterial activity
In vitro anti-mycobacterial activity showed that all the com-
pounds are bioactive against M. tuberculosis H37Rv. From
Table 8, Compounds 4c and 4e showed very good % inhibition
72.9% and 70.32% against M.tuberculosis H37RV. Also com-
pounds 4a, 4g, 4j, 4k and 4l exhibited good antimycobacterial
activity (% inhibition 67.74%, 68.38%, 60%, 64.51% and
65.80%) against M.tuberculosis H37RV. The compounds 4b,
4d and 4h showed moderate to good antimycobacterial activity
(% inhibition 58%, 51.61% and 57.41%) against M.tuberculo-
sis H37RV. Compounds 4f, displayed less antimycobacterial
activity (% inhibition 47.71%) toward M.tuberculosis H37RV.
4. Conclusion
In summary, we have described a novel, efficient, one pot, three
component reaction of some typical 2-aminobenzothiazole derivatives,
pyridine 2-aldehyde and ethyl acetoacetate to develop ethyl 2-methyl-
4-(pyridin-2-yl)-4H-benzo[4,5]thiazolo[3,2-a]pyrimidine-3-carboxylate
derivatives using PdCl2 as a prompt catalyst under microwave assisted
solvent-free conditions. The simple one-pot nature of the reaction
makes it an interesting approach. The main advantages of this current
methodology are novel with operational simplicity, good yields, simple
workup, superficial automation, without any anhydrous conditions.
The reactions were carried out under solvent free condition which
are considerably safer, nontoxic, and environmental friendly. Further-
more, the existence of three different important heterocyclic moieties
such as benzothiazole, pyridine, and pyrimidine rings in one molecule
is fantastic on account of the potential applications of these derivatives
in biological and pharmacological activities. The synthesized com-
pounds were evaluated in vitro antibacterial and antioxidant activities.
The antibacterial data revealed that the all synthesized compounds
proved to be active against the test organism, two gram negative and4H-pyrimido[2,1-b]benzothiazoles derivatives: One pot, solvent-free microwave
16), http://dx.doi.org/10.1016/j.arabjc.2016.01.012
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Moreover, all the synthesized compounds were evaluated as antioxi-
dants according to a DPPH radical scavenging activity, superoxide
anion scavenging assay and ABTS+ radical scavenging activity of
our synthesized compound. All compounds showed moderate to good
antioxidant activity. We have also screened antitubercular activity
against Mycobacterium tuberculosis H37RV strain. Compounds 4c
and 4e showed very good % inhibition 72.9% and 70.32% respectively
against M.tuberculosis H37RV and other compound showed moderate
to good antitubercular activity. Further optimization and pharmacoki-
netic characterization of this series are in progress in our laboratory.
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ited with Cambridge Crystallo graphic Data Centre as supple-
mentary CCDC 1048059, respectively. These data can be
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html or from the Cambridge Crystallographic Data Centre,
12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223
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